The uninsured rate has fallen to a new low of 9 percent, marking 16.3 million more people with health insurance since ObamaCare’s coverage expansion took effect in 2013, according to data released Thursday. The survey from the Centers for Disease Control and Prevention (CDC) finds that the uninsured rate was 9 percent in the first six months ...
Dignity Health and Kaiser Permanente have agreed to joint ownership of St. Joseph’s Medical Center in Stockton. Dignity Health will keep an 80 percent ownership interest in the hospital and related operations. Kaiser will buy a 20 percent interest, the two companies announced Monday. The deal is expected to close in mid-2016. The agreement creates ...
A section of the wall where Providence Speech and Hearing Center in Orange honors its donors is reserved for a select few “Giant Sequoias” of generosity. Among them are John M. Word III and Edward “Rusty” Brown Jr. The founders of The Word & Brown Cos., an innovator in the area of insurance services and ...
The nation’s insurance commissioners are recommending sweeping new standards to address complaints from consumers about limited access to doctors and hospitals in health plans sold under the Affordable Care Act. Limited networks of health care providers are a feature of many insurance policies offered in the public marketplaces, or exchanges, where people with low incomes ...
Health plans that offer coverage of doctors and hospitals outside the plan’s network are getting harder to find on the insurance marketplaces, according to two analyses published this week. Two-thirds of the 131 carriers that offered silver-level preferred provider organization plans in 2015 will either drop them entirely or offer fewer of them in January, ...
A Senate committee has started an investigation into the large drug price increases by Turing Pharmaceuticals and three other companies, responding to public concern about escalating prices for critical medicines. The Senate’s Special Committee on Aging requested documents and information on Wednesday from Turing, Valeant Pharmaceuticals and two other drug makers already under scrutiny for ...